A new role for an old enemy.

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• The protein kinase AKT is a key regulator of cell survival and proliferation.
• AKT plays a critical role in promoting tumor growth and progression.
• Current therapeutic strategies primarily target the enzymatic activity of AKT.

Purpose of the Study:

• To investigate the therapeutic potential of targeting AKT's structural conformation.
• To compare the efficacy of allosteric AKT inhibitors with traditional enzymatic inhibitors.

Main Methods:

• Utilized structural biology techniques to identify allosteric binding sites on AKT.
• Developed and tested novel small molecules designed to modulate AKT conformation.
• Assessed the anti-tumor activity of these compounds in preclinical cancer models.

Main Results:

• Allosteric AKT inhibitors demonstrated significant anti-proliferative effects.
• Modulating AKT's shape led to a more sustained inhibition of downstream signaling pathways.
• These conformation-targeting drugs showed improved efficacy compared to enzymatic inhibitors in relevant models.

Conclusions:

• Targeting the structural dynamics of AKT offers a promising therapeutic avenue.
• Allosteric inhibition represents a potentially superior strategy for AKT-targeted cancer therapy.
• Further development of conformation-based AKT inhibitors is warranted for clinical application.